Etsuko Yamazaki

1.9k total citations
93 papers, 1.0k citations indexed

About

Etsuko Yamazaki is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Etsuko Yamazaki has authored 93 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 25 papers in Pathology and Forensic Medicine and 17 papers in Genetics. Recurrent topics in Etsuko Yamazaki's work include Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (21 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Etsuko Yamazaki is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (21 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Etsuko Yamazaki collaborates with scholars based in Japan and United States. Etsuko Yamazaki's co-authors include Yukitoshi Takahashi, Tateki Fujiwara, Yoshiaki Ishigatsubo, Heiwa Kanamori, Naoto Tomita, Shin Fujisawa, Rika Sakai, Katsumichi Fujimaki, Yuko Kubota and Hiroyuki Fujita and has published in prestigious journals such as Blood, Frontiers in Microbiology and Epilepsia.

In The Last Decade

Etsuko Yamazaki

89 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Etsuko Yamazaki Japan	19	313	257	241	175	153	93	1.0k
Stefan M. Weiner Germany	21	274 0.9×	208 0.8×	73 0.3×	46 0.3×	145 0.9×	56	1.4k
J Dehais France	17	202 0.6×	70 0.3×	91 0.4×	73 0.4×	73 0.5×	44	1.1k
Magnus Hansson Sweden	22	115 0.4×	218 0.8×	474 2.0×	59 0.3×	281 1.8×	42	1.6k
B. Storch–Hagenlocher Germany	19	594 1.9×	176 0.7×	90 0.4×	60 0.3×	259 1.7×	54	1.9k
Folke D. Lindström Sweden	19	97 0.3×	109 0.4×	266 1.1×	129 0.7×	235 1.5×	55	1.5k
A. S. D. Spiers United Kingdom	23	296 0.9×	503 2.0×	644 2.7×	707 4.0×	238 1.6×	93	1.9k
Marie France Fassotte Belgium	14	1.2k 3.7×	251 1.0×	87 0.4×	132 0.8×	94 0.6×	25	1.9k
Ana M. Ortiz Spain	18	63 0.2×	74 0.3×	105 0.4×	53 0.3×	160 1.0×	42	835
Andrew J. Ball United Kingdom	22	82 0.3×	177 0.7×	169 0.7×	24 0.1×	506 3.3×	58	1.5k
F. González‐Crussi United States	27	465 1.5×	219 0.9×	57 0.2×	41 0.2×	752 4.9×	76	2.3k

Countries citing papers authored by Etsuko Yamazaki

Since Specialization

Citations

This map shows the geographic impact of Etsuko Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuko Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuko Yamazaki more than expected).

Fields of papers citing papers by Etsuko Yamazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuko Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuko Yamazaki. The network helps show where Etsuko Yamazaki may publish in the future.

Co-authorship network of co-authors of Etsuko Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Etsuko Yamazaki. A scholar is included among the top collaborators of Etsuko Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuko Yamazaki. Etsuko Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tachibana, Takayoshi, Takaaki Takeda, Yotaro Tamai, et al.. (2025). Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia. Experimental Hematology. 144. 104746–104746. 1 indexed citations

Nishida, Takuji, Hitoshi Ikeda, Hiroko Ikeda, et al.. (2025). Long‐term seizure and psychosocial outcomes of patients with ring chromosome 20 syndrome: A cohort study of 47 cases. Epilepsia. 66(7). 2444–2453. 1 indexed citations

Hayakawa, Fumihiko, Naoki Mori, Kiyotoshi Imai, et al.. (2024). Nelarabine‐combined chemotherapy improves outcome of T‐cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T‐ALL213‐O. Cancer Science. 116(2). 453–461. 1 indexed citations

Hatta, Yoshihiro, Koji Izutsu, Makoto Onizuka, et al.. (2024). JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL. International Journal of Hematology. 120(4). 394–413. 1 indexed citations

Kunimoto, Hiroyoshi, Ayaka Miura, Ayaka Maeda, et al.. (2023). Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome. International Journal of Hematology. 118(4). 494–502. 4 indexed citations

Fujisawa, Shin, Taisei Suzuki, Yoshimi Ishii, et al.. (2020). Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. International Journal of Hematology. 112(1). 46–56. 18 indexed citations

Kako, Shinichi, Yoshinobu Kanda, Makoto Onizuka, et al.. (2018). Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study. Blood. 132(Supplement 1). 2101–2101.

Fujisawa, Shin, Taisei Suzuki, Jun Aoki, et al.. (2017). Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma. Blood. 130. 5221–5221. 1 indexed citations

Fujisawa, Shin, Taisei Suzuki, Jun Aoki, et al.. (2017). Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome. Blood. 130. 4562–4562. 3 indexed citations

10.

Yamazaki, Etsuko, Yoshimi Ishii, Wataru Yamamoto, et al.. (2017). Body mass index is a prognostic factor in adult patients with acute myeloid leukemia. International Journal of Hematology. 105(5). 623–630. 10 indexed citations

11.

Tachibana, Takayoshi, Masatsugu Tanaka, Maki Hagihara, et al.. (2015). Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia. International Journal of Hematology. 102(4). 451–459. 1 indexed citations

12.

Umegaki, Takeshi, et al.. (2014). Impact of steroid medication before hospital admission on barotrauma in mechanically ventilated patients with acute respiratory distress syndrome in intensive care units. Journal of Anesthesia. 28(5). 681–686. 5 indexed citations

13.

Ishii, Yoshimi, Naoto Tomita, Ukihide Tateishi, et al.. (2014). The rate of reduction in the maximum standardized uptake value from the initial to the post-R-CHOP therapy in positron emission tomography scan predicts disease progression in diffuse large B cell lymphoma patients. Medical Oncology. 31(3). 880–880. 3 indexed citations

14.

Tomita, Naoto, Rika Sakai, Shin Fujisawa, et al.. (2012). SIL index, comprising stage, soluble interleukin‐2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B‐cell lymphoma. Cancer Science. 103(8). 1518–1523. 18 indexed citations

15.

Takahashi, Yukitoshi, et al.. (2009). A substantial number of Rasmussen syndrome patients have increased IgG, CD4⁺ T cells, TNFα, and Granzyme B in CSF. Epilepsia. 50(6). 1419–1431. 54 indexed citations

16.

Miyazaki, Takuya, Katsumichi Fujimaki, Yukari Shirasugi, et al.. (2007). Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: Relationship with type of latent Epstein‐Barr virus infection. American Journal of Hematology. 82(12). 1106–1109. 78 indexed citations

17.

Inoue, Yumiko, et al.. (2000). Role of Nurses in Offering Informed Consent to Clinical Trials for Advanced Lung Cancer.. Haigan. 40(7). 719–723. 1 indexed citations

18.

Meshitsuka, Shunsuke, et al.. (1999). Nuclear magnetic resonance studies of synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Clinica Chimica Acta. 281(1-2). 163–167. 27 indexed citations

19.

Ueda, Seiji, Heiwa Kanamori, Shin Sasaki, et al.. (1998). Isolated extramedullary relapse in knee joint after allogeneic bone marrow transplantation for Ph ALL. Bone Marrow Transplantation. 21(3). 319–321. 8 indexed citations

20.

Kanamori, Heiwa, Shin Sasaki, Etsuko Yamazaki, et al.. (1997). Eradication of minimal residual disease during graft-versus-host reaction induced by abrupt discontinuation of immunosuppression following bone marrow transplantation in a patient with Ph 1 -ALL. Transplant International. 10(4). 328–330. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact